Trinity Biotech plc - American Depositary Shares (TRIB)
1.6200
-0.2900 (-15.18%)
NASDAQ · Last Trade: Aug 17th, 8:10 PM EDT
Detailed Quote
Previous Close
1.910
Open
1.640
Bid
1.480
Ask
1.500
Day's Range
1.380 - 1.750
52 Week Range
0.4800 - 3.440
Volume
4,008,815
Market Cap
135.44M
PE Ratio (TTM)
-32.40
EPS (TTM)
-0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
10,285,371
Chart
About Trinity Biotech plc - American Depositary Shares (TRIB)
Trinity Bio is a biotechnology company focused on developing innovative therapies and diagnostics for various medical conditions. The company leverages advanced technologies to create solutions aimed at enhancing patient care and improving health outcomes. By prioritizing research and development, Trinity Bio strives to bring cutting-edge products to market that address unmet medical needs, while also engaging in partnerships and collaborations within the healthcare sector to expand its reach and efficacy in the industry. Read More
Trading volume in Trinity Biotech spiked to more than 1,160 times its daily average after regulators cleared the PreClara Ratio test, which helps doctors identify pregnant patients at risk of developing severe preeclampsia.
Loop Industries, Inc. (Nasdaq: LOOP), a leader in 100% recycled PET plastic and polyester fiber, has reached a key milestone in its India growth strategy by securing a 93-acre site in Gujarat for its first Infinite Loop™ manufacturing facility in the country. Strategically positioned within a Petroleum, Chemicals and Petrochemicals Investment Region (PCPIR) near Surat—widely recognized as India’s synthetic textile capital—the location provides direct and plentiful access to polyester textile waste feedstock, a critical resource for Loop’s recycling technology. The site’s proximity to a deep-water seaport will facilitate cost-efficient global resin exports, while the availability of a highly skilled petrochemical workforce in the region is expected to accelerate construction, commissioning, and operational readiness.
Synergy CHC Corp. (NASDAQ: SNYR), a consumer health and wellness company, has reported its financial results for Q2 2025, marking its tenth consecutive quarter of profitability . The company posted revenue of $8.1 million, gross margin of 76.7%, and net income of $1.5 million—up 125% year-over-year—with earnings per share rising 86% to $0.17. EBITDA surged 136% to $3.8 million. See Entire Press Release.
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
PALM BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Due to the expanding consumption of illicit drugs & alcohol across the globe the Drug Screening market is poised to grow substantially in the coming years. Drug abuse and alcohol consumption are growing worldwide. According to the World Drug Report 2023, in 2021, 1 in every 17 people aged 15–64 in the world had used a drug in the past 12 months. The number of users grew from 240 million in 2011 to 296 million in 2021 or 5.8% of the global population aged 15-64. This is a 23% increase, partly due to population growth. Other drugs like Cannabis the second most used drug, with an estimated 219 million users i.e. 4.3% of the global adult population in 2021. In 2021, according to the US Department of Transportation, National Highway Traffic Safety Administration (NHTSA), 13,384 people died in alcohol-impaired driving crashes, i.e. a 14% rise from last year. A report from MarketsAndMarkets projected that: “The global drug screening market, valued at US$7.7 billion in 2023, is forecasted to grow at a robust CAGR of 16.6%, reaching US$9.1 billion in 2024 and an impressive US$19.5 billion by 2029.North America dominates the drug screening market. This market is projected to reach USD 9.3 billion by 2029, at a CAGR of 16.4% during the forecast period. The expanding consumption of illicit drugs & alcohol will advance raise the development of drug screening products & services on the road, thereby driving the overall market growth.” Active companies in news today include: Intelligent Bio Solutions Inc. (NASDAQ: INBS), Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), bioAffinity Technologies, Inc. (NASDAQ: BIAF), Trinity Biotech plc (NASDAQ: TRIB), SOBR Safe, Inc. (NASDAQ: SOBR).
